Ref.: BL-RE-092308Manufacturer ref.: EM30RBX5 5 x 96 tests
€2,950.00 excl. VAT
Mouse FAS/TNFRSF6/Apo-1 quantitates mouse FAS/TNFRSF6/Apo-1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse FAS/TNFRSF6/Apo-1.
Accession number
Ai196731 ; ALPS1A ; APO1 ; APO-1 ; antigène Apo1 ; antigène apo-1 ; antigène de surface cellulaire APO-1 ; Apo-1 Fas ; antigène d’apoptose 1 ; récepteur de signalisation d’apoptose FAS ; antigène de surface médiant l’apoptose FAS ; APT1 ; CD95 ; antigène CD95 ; fas ; FAS (membre 6 de la superfamille des récepteurs TNF) ; Fas (membre de la superfamille des récepteurs TNF) ; Fas (superfamille des récepteurs TNF, membre 6) ; Fas AMA ; antigène Fas ; antigène Fas (ATP1) ; récepteur de mort de surface cellulaire FAS ; récepteur Fas ; FAS1 ; récepteur FASLG ; FASTM ; lpr ; lymphoprolifération ; OTTHUMP00000020045 ; OTTHUMP00000020046 ; OTTHUMP00000020051 ; OTTHUMP00000059646 ; membre 6 de la superfamille du récepteur TNF ; TNFR6 ; Tnfrsf6 ; membre 6 de la superfamille du récepteur du facteur de nécrose tumorale ; superfamille du récepteur du facteur de nécrose tumorale, membre 6
Dose range
8.2 to 2.000 pg/ml
Sensitivity of the dosage
8.2 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Mouse FAS/TNFRSF6/Apo-1 quantitates mouse FAS/TNFRSF6/Apo-1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse FAS/TNFRSF6/Apo-1.
Mouse FAS/TNFRSF6/Apo-1 quantitates mouse FAS/TNFRSF6/Apo-1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse FAS/TNFRSF6/Apo-1.
FAS (Fas, CD95, APO-1) is a 46 kDa transmembrane glycoprotein that works as a cell death receptor in the TNFR superfamily (tumoral necrosis factor receptor). FAS also exists in a soluble form, weighing about 26 kDa. Stimulation of FAS results in the aggregation of its intracellular death domains associated with FAS (FADD), formation of the death-inducing signaling complex (DISC) and activation of caspases. Self-proteolytic treatment of the caspases in the complex triggers a downstream cascade that leads to apoptosis. FAS has been shown to activate NF-kappaB, MAPK3/ERK1, MAPK8/JNK, and is involved in the transduction of proliferation signals in normal diploid fibroblasts and T cells. At least eight variants of spliced transcription coding seven distinct isoforms were described. Isoforms without transmembrane domain can negatively regulate the apoptosis mediated by the full length isoform. The Fas/Fas ligand system has been shown to play a role in a number of human diseases, such as AIDS, hepatitis or cancer. It is also assumed that the induction of apoptosis via FAS ligand is predominantly involved in antiviral immune responses.
Sensitivity
Sensitivity of dosage: 8.2 pg/ml.
Measurement range
Dose range: 8.2 to 2.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: FAS (CD95).
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).